Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 90
Summary
- Conditions
- Locally Advanced Malignant Neoplasm
- Lung Cancer Metastatic
- Non Hodgkin Lymphoma
- Urologic Neoplasms
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03595813
- Collaborators
- Cancer Research Center of Marseille
- Investigators
- Not Provided
Get Well Soon